ForePass Shows Surgery-Like Benefits While Advancing a Less Invasive Approach to Obesity Treatment Keyron has announced the publication of new preclinical research in Gut, one of the world’s highest-ranked gastroenterology journals, highlighting the potential of its ForePass endoscopic metabolic bypass…
JCR Pharmaceuticals Showcases Preclinical Gene Therapy Findings Demonstrating Strong CNS Uptake at the American Society of Gene and Cell Therapy 29th Annual Meeting JCR Pharmaceuticals presented new preclinical findings highlighting the potential of its proprietary JUST-AAV gene therapy platform during…
ImmunityBio Secures U.S. Patent Protection Through 2035 for ANKTIVA-BCG Combination Cancer Therapy ImmunityBio has announced the issuance of five United States patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guérin for the treatment of cancer, significantly…
Agenus Publishes Promising Phase 1b Data for Botensilimab and Balstilimab Combination in Advanced Liver Cancer Agenus has announced the publication of new clinical data highlighting the potential of its investigational immunotherapy combination of botensilimab and balstilimab in patients with advanced…
Bayer Launches Midol in Motion Campaign to Support PMS Symptom Relief Through Movement and Education Bayer has announced the launch of “Midol in Motion,” a new awareness and education campaign designed to help menstruators better understand and manage common premenstrual…
Affinia Therapeutics Highlights Advances in Gene Therapy Pipeline and Manufacturing at ASGCT 2026 Affinia Therapeutics showcased major progress across its cardiovascular and central nervous system gene therapy programs during multiple presentations at the 29th Annual Meeting of the American Society…
New Heart Failure 2026 Analyses Highlight Consistent Clinical Benefits of Vutrisiran Across Diverse ATTR-CM Patient Groups Alnylam Pharmaceuticals has announced new analyses from its Phase 3 HELIOS-B clinical trial evaluating vutrisiran in patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), providing…
Dyno Therapeutics Expands Frontiers Network and Unveils Second Annual Genetic Agency Technology Conference Dyno Therapeutics, a biotechnology company focused on applying artificial intelligence to advance in vivo gene delivery, has announced major updates to two of its strategic initiatives aimed…
Dr. Carrie Leff Opens Concierge Women’s Primary Care Clinic Focused on Midlife Wellness in Farmington Hills Dr. Carrie Leff, a board-certified internist and Menopause Society Certified Practitioner, has officially launched a new concierge-style women’s primary care practice focused on delivering…
MinuteClinic and Hartford HealthCare Expand Collaboration to Offer In-Network Adult Primary Care Across Connecticut MinuteClinic, the retail medical clinic network located within select CVS Pharmacy stores, and Hartford HealthCare, one of New England’s largest integrated healthcare systems, have announced an…
Erbe Highlights New MOVIVA® Endoscopic Obesity Therapy Platform During 175th Anniversary Year Erbe Elektromedizin GmbH is marking its 175th anniversary by showcasing continued innovation in minimally invasive healthcare technologies with the launch of MOVIVA®, a new solution designed for gastric…
Reprieve Cardiovascular Reports Published FASTR Pilot Study Results Supporting Potential New Approach for Acute Heart Failure Treatment Reprieve Cardiovascular, a development-stage medical technology company focused on transforming the treatment of acute decompensated heart failure (ADHF), has announced the publication of…